ArticleJournal of clinical medicine2022

Comparison of Rheumatoid Arthritis Patients' 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates.

Laetitia Diep et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.